This inventor holds 1 USPTO granted patent. Top assignee: Quest Diagnostics Investments, Inc.. Active years: 2015.
Company Filing History:
Years Active: 2015
Title: **Innovative Contributions of Emberlee Eleazar in Pathogen Detection**
Introduction
Emberlee Eleazar, an accomplished inventor based in Anaheim, CA, has made significant strides in the field of biotechnology. With her dedication to advancing methods for pathogen detection, she holds one patent that exemplifies her innovative spirit and commitment to public health.
Latest Patents
Emberlee is the inventor of a patent titled "Direct amplification and detection of viral and bacterial pathogens." This groundbreaking patent offers methods for identifying the presence or absence of target nucleic acids from microorganisms using direct amplification, without requiring the extraction of nucleic acids. This technique ensures that the specificity and sensitivity of traditional methods remain intact, making it a game-changer for diagnostics.
Career Highlights
Currently, Emberlee Eleazar is a valuable member of Quest Diagnostics Investments, Inc., a prominent company in the healthcare sector focused on diagnostic testing and information services. Her work at Quest Diagnostics showcases her expertise and innovative approach to solving complex challenges in pathogen detection.
Collaborations
Throughout her career, Emberlee has collaborated with talented colleagues, including Maurice Exner and Luca Jacky. Working together has allowed them to explore new possibilities in their respective fields and contribute to significant advancements in diagnostic technologies.
Conclusion
Emberlee Eleazar's contributions to the field of pathogen detection highlight her exceptional talent as an inventor. Her patent not only showcases her innovative thinking but also addresses critical needs in public health. As she continues her work at Quest Diagnostics, Emberlee remains a prominent figure in the realm of biotechnology, paving the way for future innovations.